3Ahmedin J, Freddie B, Melissa M, et al . Global cancer statidtics [J]. CA Cancer J Clin,2011 ,61 :69-90.
4Mario P. HE4 in gynecological cancers: report of a European investigators and experts meeting [J]. Clin Chern Lab Med, 2012,50: 2127-2136.
5Laura Z .Eliana B ,Stefano C;et al. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome [J]. Clin Chern Lab Med,2012,50:2189-2198.
6Moore RG , Brown AK , Mille MC .et al. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus [J]. Gynecol Oncol , 2008,110: 196- 201.
7Bignotti E,Ragnoli1 M,Zanotti L.etal. Diagnostic and prog- nostic impact of serum HE4 detection in endometrial carcinoma patients [J]. Brit J Cancer ,2011,10: 1-8.
8Moore RG, Mille MC ,Brown AK, et al . Utility of tumor marker HE4 to predict depth of myometrial invasion in endometrioid adenocarcinoma of the uterus. [J]. Int J Gynecol Cancer,2011,21:1185-1190.
9Kalogera E ,Scholler Nv Powless C,et al . Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer [J]. Gynecol Oncol , 2011,10 : 1016-1022.
10Kirchhoff C. Molecular characterization of epididymal proteins [J]. Rev Reprod,1998,3:86-95.
